TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched Glipizide 2.5mg Tablets on the TruPharma label. The FDA-approved products are being supplied to TruPharma pursuant to an agreement with Rubicon Research Private Limited. Significantly, Rubicon holds the only FDA approval for a 2.5 mg strength Glipizide Tablet product, and TruPharma will be the sole source supplier to the market for this item.